Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Clinical trial NCT04172532 · RECRUITING

Trial details

NCT number: NCT04172532
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Adenocarcinoma Stage III Pancreatic Cancer AJCC v8

Start date: 2021-01-11
Primary completion: 2027-08-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.